Byetta 5 mcg

Exenatide 5 mg.

Pharmacology
Mechanism of Action
A glucagonlike peptide-1 (GLP-1) that mimics incretin and promotes insulin secretion, suppresses glucagon, and slows gastric emptying

Absorption
Peak plasma time: 2.1 hr
Peak plasma concentration: 211 pg/mL
AUC: 1036 pg·hr/mL

Distribution
Vd: 28.3 L

Metabolism
Proteolytic degradation following glomerular filtration

Elimination
Half-life: 2.4 hr (immediate release); 2 weeks (extended release)
Renal clearance: 9.1 L/hr
Excretion: Urine (primarily)

next: Administration →

← prev: Pregnancy and Breastfeeding Warnings

Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Byetta 5 mcg only for the indication prescribed.

Verified References
  • FDA Feb 11, 2018
  • CDC Feb 11, 2018
  • Mayo Clinic Feb 11, 2018
  • Drugs.com accessed Feb 11, 2018
  • Medscape accessed Feb 11, 2018
  • Epocrates accessed Feb 11, 2018
  • Webmd accessed Feb 11, 2018
    •

© 2021 Drugviewer. All rights reserved.

Information on this website is provided for Educational Purposes ONly and is not meant to replace advice of healthcare professional. Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care.

Reviews on this website is NOT intended to endorse drugs, entities or recommend a specific therapy. While these reviews might be helpful, they are not a substitute for the expertise, skill, knowledge and judgement of healthcare practitioners in patient care.

Prices on this website are different among countries. As a standardization, the prices will reflect that of the United States, Dollars ($USD).

Please note that Drugs which requires a prescriptions from a licensed professional will be labeled. Copay may be different based on your specific insurance carrier.

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances. If you have any questions or concerns, please send us a detailed message to info@drugviewer.com. We will make every effort to resolve your concerns.

Copyright notice: All logo, Image, branding, tradenames, trademarks are owned by the perspective entities. DrugViewers does not endorse or claim ownership of any.